- Malignant lymphomas
- Leukemias
- Retinoblastoma
- Carcinoma of breast
- Ovarian cancer
- Mycosis fungoides
- Minimal Change Nephrotic Syndrome in Pediatric Patients
CYCLOXAN 1000
MRP | : |
|
Price | : | ₹100.00 |
You Save | : | ₹84.00 (45.65%) |
1 vial(s)
Cycloxan 1gm Injection is a chemotherapy drug containing the active constituent cyclophosphamide. It is used to treat various malignancies (abnormal cell production leading to cancer that can spread to other organs). Cycloxan 1gm Injection is indicated for malignant lymphomas (cancers originating in the lymphatic system), including Hodgkin’s disease, lymphocytic lymphoma, and mixed-cell type lymphoma.
It is also used to treat leukemias, neuroblastoma, ovarian cancer, retinoblastoma, and breast carcinoma. Additionally, it can treat Minimal Change Nephrotic Syndrome in pediatric patients (a kidney disease characterized by significant protein loss in urine).
Cycloxan 1gm Injection is contraindicated in pregnancy, and in patients with acute infections, urinary tract infections, urinary outflow obstruction, and bone marrow disorders.
Treatment with this medicine may lead to several serious side effects, including immune suppression, bone marrow failure, cardiotoxicity, renal toxicity, pulmonary toxicity, and secondary malignancies. It is crucial to inform your doctor if you have pre-existing kidney disease, immune conditions, cardiac disorders, or liver diseases before starting this treatment